Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury (ASCI) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SUN13837 injection for acute spinal cord injury has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• SUN13837

Snippet

Sponsor: Daiichi Sankyo | Conditions: Acute Spinal Cord Injury | Phase 2 | Status: COMPLETED | Results posted: 2021-01-15